Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GBA1 | P04062 | 1/20 | 0.44 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | PYGB | P11216 | 3/20 | 0.33 |
| ▸ | TREH | O43280 | 1/20 | 0.33 |
| ▸ | CDA | P32320 | 5/20 | 0.32 |
| ▸ | PYGL | P06737 | 1/20 | 0.32 |
| ▸ | PYGM | P11217 | 1/20 | 0.32 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6509721 | 1.00 | LMNA (0.44) | LMNAGBA1NLRP3PYGBTREH | |
| SCHEMBL504610 | 1.00 | LMNA (0.44) | LMNAGBA1NLRP3PYGBTREH | |
| SCHEMBL346819 | 1.00 | LMNA (0.44) | LMNAGBA1NLRP3PYGBTREH | |
| SCHEMBL14124884 | 1.00 | LMNA (0.44) | LMNAGBA1NLRP3PYGBTREH | |
| Water SCHEMBL6533488 | 0.98 | LMNA (0.42) | LMNAGBA1NLRP3PYGBTREH | |
| Water SCHEMBL27487332 | 0.98 | LMNA (0.42) | LMNAGBA1NLRP3PYGBTREH | |
| Phosphoric Acid SCHEMBL21495145 | 0.93 | LMNA (0.39) | LMNAGBA1NLRP3TREH | |
| SCHEMBL16684264 | 0.87 | — | — | |
| SCHEMBL6531031 | 0.84 | LMNA (0.35) | LMNAGBA1 | |
| SCHEMBL14817456 | 0.80 | LMNA (0.37) | LMNAGBA1NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2025-01-16 | — | — | US | claimed |
| US-12137706-B2 | Micro-encapsulated aquaculture feed | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (JP) | 2024-11-12 | — | — | US | claimed |
| EP-4433077-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL Business Ltd (GB) | 2024-09-25 | — | — | EP | claimed |
| WO-2023089313-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2023-05-25 | — | — | WO | claimed |
| WO-2022059694-A1 | COMPOSITION FOR IMPROVING RENAL FUNCTION | 国立大学法人鹿児島大学 | 2022-03-24 | — | — | WO | claimed |
| EP-3504174-A1 | METHOD FOR THE PRODUCTION OF GLYCOLS FROM AN ANHYDROSUGAR FEED | Shell Internationale Research Maatschappij B.V. (NL) | 2019-07-03 | — | — | EP | claimed |
| US-20190194100-A1 | METHOD FOR THE PRODUCTION OF GLYCOLS FROM AN ANHYDROSUGAR FEED | SHELL OIL COMPANY | 2019-06-27 | — | — | US | claimed |
| CN-108034694-B | A kind of detection kit and its detection method of 1,5- anhydro sorbitol | 广州市进德生物科技有限公司 | 2019-01-04 | — | — | CN | claimed |
| CN-108034694-A | A kind of detection kit and its detection method of 1,5- anhydro sorbitols | 广州市进德生物科技有限公司 | 2018-05-15 | — | — | CN | claimed |
| WO-2018039109-A1 | METHOD FOR THE PRODUCTION OF GLYCOLS FROM AN ANHYDROSUGAR FEED | SHELL OIL COMPANY (US) | 2018-03-01 | — | — | WO | claimed |
| US-20030170832-A1 | Ascopyrone P synthase | DANISCO A/S (DK) | 2003-09-11 | — | — | US | claimed |
| US-20030170829-A1 | 1,5-Anhydro-D-fructose dehydratase | DANISCO A/S (DK) | 2003-09-11 | — | — | US | claimed |
| WO-2003038085-A1 | 1,5-ANHYDRO-D-FRUCTOSE DEHYDRATASE | DANISCO A/S (DK) | 2003-05-08 | — | — | WO | claimed |
| WO-2003038084-A1 | ASCOPYRONE P SYNTHASE | DANISCO A/S (DK) | 2003-05-08 | — | — | WO | claimed |
| WO-2003038107-A2 | PROCESS FOR THE PRODUCTION OF ASCOPYRONE P | DANISCO A/S (DK) | 2003-05-08 | — | — | WO | claimed |
| WO-2003037918-A2 | PYRANOSONE DEHYDRATASE FROM PHANEROCHAETE CHRYSOSPORIUM | DANISCO A/S (DK) | 2003-05-08 | — | — | WO | claimed |
| CN-1394142-A | Use of cyclic ethers for the manufacture of a medicament for influencing glucose tolerance | DANISCO (DK) | 2003-01-29 | — | — | CN | claimed |
| US-5695970-A | SUGAR SUBSTITUTES | T&M BIOPOLYMER AKTIEBOLAG (SE) | 1997-12-09 | — | — | US | claimed |
| EP-0665881-A1 | A NEW GLUCAN LYASE PRODUCING 1,5-ANHYDROFRUCTOSE | T & M BIOPOLYMER AKTIEBOLAG (SE) | 1995-08-09 | — | — | EP | claimed |
| WO-1994009122-A1 | A NEW GLUCAN LYASE PRODUCING 1,5-ANHYDROFRUCTOSE | ALGATECH AB (SE) | 1994-04-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194100-A1 | METHOD FOR THE PRODUCTION OF GLYCOLS FROM AN ANHYDROSUGAR FEED | ALDOA, SORD, DERA | LMNA 4599/4885GBA1 287/4885NLRP3 4422/4885 |
| US-20030170832-A1 | Ascopyrone P synthase | COASY, DHPS, FDPS | LMNA 2647/4885GBA1 3688/4885NLRP3 1508/4885 |
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | POLRMT, TK2, GOT2 | LMNA 2348/4885GBA1 498/4885NLRP3 3827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.